FDA product code KQH: Red-Cell Indices

KQH is the FDA product code for red-cell indices. It is a Class II device, regulated under 21 CFR 864.5300 and reviewed by the Hematology panel. FDA has cleared 1 510(k) submission under KQH. The average 510(k) review took 38 days (median 38).

Classification

FieldValue
Device nameRed-Cell Indices
Device classClass II
Regulation21 CFR 864.5300
Review panelHE — Hematology
Medical specialtyHematology
Premarket route510(k)
Third-party 510(k) review eligibleYes

Compare with all 510(k) review times · Search every KQH clearance

Top KQH applicants

ApplicantClearancesLatest
V.Marc, A Div. of Pictorial, Inc.11986-07-10

Most recent KQH clearances

510(k)ApplicantDeviceDecision dateReview days
K862089V.Marc, A Div. of Pictorial, Inc.V-MARC 88A COMPUTER1986-07-1038

Recalls for KQH devices

openFDA lists no recalls for product code KQH.

Frequently asked questions

What is FDA product code KQH?

KQH is the FDA product code for red-cell indices. It is a Class II device, regulated under 21 CFR 864.5300 and reviewed by the Hematology panel.

What device class is KQH?

Class II, regulation 21 CFR 864.5300. Typical premarket route: 510(k).

How long does a 510(k) take for product code KQH?

Across 1 cleared submissions the average was 38 days from receipt to decision (median 38).

Which companies have the most KQH clearances?

V.Marc, A Div. of Pictorial, Inc. (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Hematology product codes · FDA product code lookup · 510(k) database search · 510(k) review times